Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.42 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.96.
Market Cap
8.42T
Revenue
4.52T
Profits
200.69B
PE Ratio
41.96
Profit Margin
4.44%
Dividend Yield
0.42%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 823.14B | -0.77% | 1,926,165 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 555.64B | -1.49% | 7,810,028 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 360.31B | -2.24% | 5,773,998 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 313.96B | -2.01% | 1,104,524 | 58.74B |
| 5 | UNH | UnitedHealth Group Incorporated | 293.61B | -0.35% | 9,049,468 | 447.57B |
| 6 | NVS | Novartis AG | 290.03B | -0.64% | 1,229,032 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 289.22B | -1.65% | 7,391,725 | 65.01B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 195.48B | -0.11% | 1,437,440 | 44.56B |
| 9 | AMGN | Amgen Inc. | 188.98B | -1.45% | 2,107,354 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 180.44B | -0.15% | 10,503,892 | 48.59B |
| 11 | GILD | Gilead Sciences, Inc. | 168.64B | -1.29% | 3,870,701 | 29.44B |
| 12 | ABT | Abbott Laboratories | 167.20B | -0.84% | 9,411,396 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 165.37B | -0.77% | 2,442,062 | 10.06B |
| 14 | PFE | Pfizer Inc. | 156.54B | -0.15% | 25,023,029 | 62.58B |
| 15 | DHR | Danaher Corporation | 138.36B | 0.39% | 5,270,918 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.58B | -1.45% | 1,158,664 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.73B | -1.73% | 7,676,658 | 48.19B |
| 18 | SNY | Sanofi | 116.73B | -0.15% | 1,997,022 | 54.85B |
| 19 | GSK | GSK plc | 115.93B | -1.71% | 3,661,304 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.71B | -0.46% | 789,396 | 12.00B |
| 21 | MDT | Medtronic plc | 109.13B | -1.38% | 8,499,399 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 106.90B | -2.02% | 734,423 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.22B | -0.85% | 582,154 | 397.96B |
| 24 | CVS | CVS Health Corporation | 98.15B | -0.93% | 7,438,461 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 90.64B | -5.04% | 16,503,841 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.90B | -0.15% | 493,843 | 14.34B |
| 27 | CI | The Cigna Group | 73.80B | 0.46% | 1,271,622 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 70.15B | -1.14% | 1,607,597 | 199.13B |
| 29 | MDLN | Medline Inc. | 63.40B | 1.30% | 3,730,200 | 28.43B |
| 30 | COR | Cencora, Inc. | 62.84B | -1.39% | 1,133,113 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 54.68B | -1.52% | 3,312,938 | 28.48B |
| 32 | ARGX | argenx SE | 51.85B | -1.72% | 217,784 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 51.61B | 0.71% | 3,802,050 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 49.69B | -1.31% | 1,368,816 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 46.95B | 0.56% | 5,509,217 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.31B | -1.05% | 638,112 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 45.17B | 0.06% | 3,301,812 | 21.92B |
| 38 | HLN | Haleon plc | 42.93B | -0.72% | 4,786,247 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.24B | 0.41% | 966,502 | 3.71B |
| 40 | ALC | Alcon Inc. | 39.20B | -1.25% | 751,396 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 37.28B | -1.17% | 4,963,531 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.27B | -1.79% | 155,006 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.18B | -0.75% | 1,252,046 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.83B | -0.68% | 2,245,507 | 20.63B |
| 45 | WAT | Waters Corporation | 32.95B | 2.39% | 748,703 | 3.17B |
| 46 | RMD | ResMed Inc. | 32.80B | -0.87% | 1,072,287 | 5.40B |
| 47 | INSM | Insmed Incorporated | 30.83B | -1.15% | 1,070,999 | 606.42M |
| 48 | RVMD | Revolution Medicines, Inc. | 30.76B | -1.61% | 3,495,317 | - |
| 49 | IQV | IQVIA Holdings Inc. | 29.67B | 0.17% | 1,049,150 | 16.31B |
| 50 | NTRA | Natera, Inc. | 29.44B | -0.32% | 801,155 | 2.31B |
| 51 | RPRX | Royalty Pharma plc | 29.23B | -1.40% | 2,524,274 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 27.82B | -1.72% | 715,516 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.58B | 0.53% | 1,606,680 | 3.20B |
| 54 | BIIB | Biogen Inc. | 26.91B | 3.38% | 1,484,372 | 9.89B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.82B | -1.19% | 115,480 | 4.03B |
| 56 | BNTX | BioNTech SE | 26.60B | 2.21% | 908,028 | 3.37B |
| 57 | HUM | Humana Inc. | 25.25B | 2.53% | 1,506,910 | 129.66B |
| 58 | UTHR | United Therapeutics Corporation | 25.13B | -2.54% | 377,450 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.94B | 1.00% | 3,766,922 | 4.66B |
| 60 | STE | STERIS plc | 22.21B | 0.27% | 460,606 | 5.83B |
| 61 | LH | Labcorp Holdings Inc. | 22.12B | -0.55% | 565,947 | 13.95B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.73B | 0.66% | 1,964,251 | 11.04B |
| 63 | MRNA | Moderna, Inc. | 21.65B | 1.62% | 5,440,186 | 1.94B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.81B | -2.51% | 4,748,377 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 20.18B | -1.22% | 987,690 | 4.34B |
| 66 | WST | West Pharmaceutical Services, Inc. | 20.02B | 1.56% | 1,008,157 | 3.07B |
| 67 | SMMT | Summit Therapeutics Inc. | 19.48B | -0.12% | 3,371,461 | - |
| 68 | INCY | Incyte Corporation | 19.29B | -0.92% | 1,033,224 | 5.14B |
| 69 | CNC | Centene Corporation | 18.84B | 0.37% | 3,164,036 | 176.15B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 18.48B | 0.74% | 1,551,248 | 8.23B |
| 71 | VTRS | Viatris Inc. | 17.31B | 1.29% | 12,792,792 | 14.30B |
| 72 | GMAB | Genmab A/S | 17.18B | -2.24% | 1,810,435 | 3.72B |
| 73 | THC | Tenet Healthcare Corporation | 16.63B | -2.74% | 1,345,376 | 21.31B |
| 74 | ASND | Ascendis Pharma A/S | 15.16B | 0.37% | 403,350 | 845.52M |
| 75 | MEDP | Medpace Holdings, Inc. | 15.09B | 1.51% | 336,695 | 2.53B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.87B | -0.09% | 1,650,391 | 502.08M |
| 77 | SNN | Smith & Nephew plc | 14.60B | -0.44% | 957,934 | 6.16B |
| 78 | PODD | Insulet Corporation | 13.91B | -1.40% | 587,013 | 2.71B |
| 79 | RGC | Regencell Bioscience Holdings Limited | 13.90B | -1.99% | 77,693 | - |
| 80 | ALGN | Align Technology, Inc. | 13.73B | 0.84% | 1,362,775 | 4.03B |
| 81 | COO | The Cooper Companies, Inc. | 13.55B | -0.86% | 1,479,765 | 4.15B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.24B | -1.25% | 1,746,486 | 2.86B |
| 83 | GMED | Globus Medical, Inc. | 13.10B | 1.65% | 855,605 | 2.94B |
| 84 | PEN | Penumbra, Inc. | 12.97B | -0.73% | 640,221 | 1.40B |
| 85 | FMS | Fresenius Medical Care AG | 12.53B | -0.98% | 692,197 | 23.05B |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 12.47B | -0.42% | 777,759 | 4.27B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.37B | -1.11% | 1,106,829 | 943.71M |
| 88 | SOLV | Solventum Corporation | 12.15B | -0.62% | 979,995 | 8.33B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | -0.92% | 292,704 | 958.40M |
| 90 | GH | Guardant Health, Inc. | 11.95B | 0.79% | 2,050,888 | 982.02M |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.83B | - | 2,691,834 | 4.72B |
| 92 | ENSG | The Ensign Group, Inc. | 11.54B | -1.28% | 257,114 | 5.06B |
| 93 | EXEL | Exelixis, Inc. | 11.33B | -2.85% | 2,045,473 | 2.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.03B | -1.58% | 1,776,842 | 3.85B |
| 95 | UHS | Universal Health Services, Inc. | 10.97B | -1.47% | 686,155 | 17.36B |
| 96 | EHC | Encompass Health Corporation | 10.56B | -0.11% | 607,302 | 5.94B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 0.44% | 1,598,443 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 10.40B | -0.99% | 984,071 | 2.86B |
| 99 | TEM | Tempus AI, Inc. | 10.18B | 1.63% | 5,826,436 | 1.27B |
| 100 | DVA | DaVita Inc. | 9.97B | 0.96% | 454,168 | 13.64B |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.80B | 1.14% | 1,334,895 | 12.91B |
| 102 | BAX | Baxter International Inc. | 9.73B | 0.69% | 6,729,236 | 11.24B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.70B | -0.37% | 1,198,670 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.65B | -0.16% | 525,007 | 638.50M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.54B | 0.02% | 328,398 | 7.46M |
| 106 | TECH | Bio-Techne Corporation | 9.48B | 2.28% | 2,012,328 | 1.22B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.39B | -4.31% | 867,647 | 5.37M |
| 108 | MASI | Masimo Corporation | 9.32B | 0.03% | 598,413 | 1.53B |
| 109 | CRL | Charles River Laboratories International, Inc. | 9.15B | 0.90% | 576,688 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 9.08B | 0.41% | 1,412,699 | 13.18B |
| 111 | ICLR | ICON Public Limited Company | 8.94B | -2.14% | 995,364 | 8.10B |
| 112 | PCVX | Vaxcyte, Inc. | 8.92B | -0.58% | 945,814 | - |
| 113 | NUVL | Nuvalent, Inc. | 8.51B | 0.59% | 392,548 | - |
| 114 | QGEN | Qiagen N.V. | 8.49B | -0.48% | 1,210,972 | 2.09B |
| 115 | IBRX | ImmunityBio, Inc. | 8.47B | 6.49% | 16,210,550 | 113.29M |
| 116 | ATR | AptarGroup, Inc. | 8.35B | 0.22% | 403,610 | 3.78B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.24B | 0.40% | 1,203,154 | 1.40B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.19B | 1.44% | 171,741 | 2.58B |
| 119 | CYTK | Cytokinetics, Incorporated | 8.15B | -0.85% | 1,027,494 | 88.04M |
| 120 | KRYS | Krystal Biotech, Inc. | 8.14B | 0.84% | 210,388 | 389.13M |
| 121 | MOH | Molina Healthcare, Inc. | 7.82B | 0.77% | 862,657 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.44B | 0.59% | 678,499 | 738.26M |
| 123 | HQY | HealthEquity, Inc. | 7.29B | 0.34% | 851,591 | 1.31B |
| 124 | GKOS | Glaukos Corporation | 7.23B | -0.19% | 442,187 | 507.44M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 7.10B | -0.89% | 375,402 | 39.21M |
| 126 | HIMS | Hims & Hers Health, Inc. | 7.07B | 7.60% | 69,287,713 | 2.35B |
| 127 | GRFS | Grifols, S.A. | 6.89B | -3.20% | 321,366 | 8.83B |
| 128 | ERAS | Erasca, Inc. | 6.75B | 14.20% | 7,627,144 | - |
| 129 | ACLX | Arcellx, Inc. | 6.75B | -0.04% | 726,511 | 22.29M |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | -0.48% | 540,470 | 46.02M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.71B | -1.39% | 483,212 | - |
| 132 | BLTE | Belite Bio, Inc | 6.51B | -0.01% | 79,177 | - |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.33B | 0.52% | 915,910 | - |
| 134 | BRKR | Bruker Corporation | 6.26B | 0.98% | 3,261,302 | 3.44B |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.38% | 1,690,543 | 15.00M |
| 136 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.17% | 4,152,864 | - |
| 137 | CAI | Caris Life Sciences, Inc. | 6.00B | 0.43% | 1,564,363 | 812.03M |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.99B | -1.09% | 596,766 | 189.76M |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.99B | -0.15% | 956,853 | 1.73B |
| 140 | BLCO | Bausch + Lomb Corporation | 5.97B | -0.36% | 219,875 | 5.10B |
| 141 | COGT | Cogent Biosciences, Inc. | 5.96B | -0.67% | 1,160,322 | - |
| 142 | CGON | CG Oncology, Inc. | 5.94B | -4.13% | 930,500 | 4.04M |
| 143 | TFX | Teleflex Incorporated | 5.84B | 0.28% | 1,004,739 | 1.99B |
| 144 | IMVT | Immunovant, Inc. | 5.81B | -2.63% | 1,501,531 | - |
| 145 | CELC | Celcuity Inc. | 5.80B | -1.94% | 937,098 | - |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 5.78B | -2.29% | 564,521 | 521.31M |
| 147 | AVTR | Avantor, Inc. | 5.75B | -0.23% | 10,593,153 | 6.55B |
| 148 | ALKS | Alkermes plc | 5.69B | -0.87% | 1,124,379 | 1.48B |
| 149 | PACS | PACS Group, Inc. | 5.66B | 2.27% | 911,785 | 5.29B |
| 150 | CRSP | CRISPR Therapeutics AG | 5.54B | -0.52% | 1,263,497 | 3.51M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.49B | -4.32% | 1,128,835 | - |
| 152 | TGTX | TG Therapeutics, Inc. | 5.46B | 4.61% | 2,481,549 | 616.29M |
| 153 | LNTH | Lantheus Holdings, Inc. | 5.46B | 0.18% | 502,993 | 1.54B |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | -4.37% | 1,120,932 | 7.50M |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.10% | 4,108,076 | 1.00B |
| 156 | CHE | Chemed Corporation | 5.17B | 0.30% | 196,651 | 2.53B |
| 157 | WAY | Waystar Holding Corp. | 5.12B | 3.53% | 1,816,369 | 1.10B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | -1.44% | 534,819 | 2.04M |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.93B | 0.39% | 722,709 | 761.41M |
| 160 | OSCR | Oscar Health, Inc. | 4.89B | 4.12% | 5,827,726 | 11.70B |
| 161 | SHC | Sotera Health Company | 4.64B | -0.12% | 1,855,752 | 1.16B |
| 162 | LEGN | Legend Biotech Corporation | 4.64B | 18.42% | 7,406,525 | 1.03B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 4.62B | -0.02% | 112,744 | 268.09M |
| 164 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,654,945 | 634.21M |
| 165 | NVST | Envista Holdings Corporation | 4.54B | 0.04% | 2,257,684 | 2.72B |
| 166 | RDNT | RadNet, Inc. | 4.53B | -4.21% | 1,019,594 | 2.04B |
| 167 | OPCH | Option Care Health, Inc. | 4.52B | -0.17% | 828,130 | 5.65B |
| 168 | DOCS | Doximity, Inc. | 4.51B | -1.30% | 3,703,238 | 637.78M |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.40B | 1.60% | 2,383,594 | 3.95B |
| 170 | STVN | Stevanato Group S.p.A. | 4.33B | 2.12% | 296,747 | 1.39B |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 4.23B | -4.67% | 1,636,724 | 3.02B |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.21B | -1.83% | 1,189,078 | 7.70M |
| 173 | MMSI | Merit Medical Systems, Inc. | 4.16B | -1.61% | 447,469 | 1.52B |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.12B | 0.94% | 1,827,744 | - |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.04B | -0.33% | 293,063 | 747.14M |
| 176 | BLLN | BillionToOne, Inc. | 4.00B | 9.49% | 793,804 | 305.11M |
| 177 | TMDX | TransMedics Group, Inc. | 3.91B | -2.36% | 735,097 | 605.49M |
| 178 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | -2.48% | 417,291 | 22.50M |
| 179 | MMED | MiniMed Group, Inc. | 3.88B | -4.36% | 555,581 | 2.99B |
| 180 | TWST | Twist Bioscience Corporation | 3.79B | 3.46% | 1,033,604 | 391.56M |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -0.36% | 1,037,485 | 1.07B |
| 182 | TNGX | Tango Therapeutics, Inc. | 3.77B | -0.94% | 1,515,979 | 62.38M |
| 183 | TVTX | Travere Therapeutics, Inc. | 3.72B | -1.18% | 1,448,579 | 490.73M |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.64B | -1.34% | 617,375 | - |
| 185 | LIVN | LivaNova PLC | 3.60B | -1.95% | 758,227 | 1.39B |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.59B | -0.09% | 189,377 | 803.79M |
| 187 | GPCR | Structure Therapeutics Inc. | 3.42B | -4.99% | 815,771 | - |
| 188 | ORKA | Oruka Therapeutics, Inc. | 3.41B | -0.07% | 1,333,381 | - |
| 189 | HNGE | Hinge Health, Inc. | 3.40B | 1.41% | 561,636 | 587.86M |
| 190 | LQDA | Liquidia Corporation | 3.32B | -4.59% | 1,503,132 | 158.32M |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.31B | -1.91% | 1,741,120 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.26B | 0.48% | 214,027 | 2.23B |
| 193 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.15% | 738,986 | - |
| 194 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.25B | -5.43% | 1,209,423 | 677.56M |
| 195 | BKD | Brookdale Senior Living Inc. | 3.22B | -1.46% | 3,422,760 | 3.05B |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.18B | -0.72% | 1,545,922 | 588.99M |
| 197 | WRBY | Warby Parker Inc. | 3.17B | 4.14% | 3,492,444 | 871.91M |
| 198 | ALMS | Alumis Inc. | 3.14B | -1.12% | 821,390 | 24.05M |
| 199 | TXG | 10x Genomics, Inc. | 3.14B | -5.71% | 3,601,708 | 642.82M |
| 200 | BEAM | Beam Therapeutics Inc. | 3.10B | -0.64% | 1,257,638 | 139.74M |
| 201 | KLRA | Kailera Therapeutics, Inc. | 3.04B | -5.35% | 1,340,999 | - |
| 202 | ITGR | Integer Holdings Corporation | 3.04B | -0.98% | 305,988 | 1.85B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | -0.24% | 887,355 | 376.07M |
| 204 | PRVA | Privia Health Group, Inc. | 3.03B | 0.25% | 469,126 | 2.12B |
| 205 | VERA | Vera Therapeutics, Inc. | 2.98B | -1.63% | 755,117 | - |
| 206 | SUPN | Supernus Pharmaceuticals, Inc. | 2.95B | -0.27% | 426,535 | 718.95M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 2.95B | -0.91% | 843,919 | 218.71M |
| 208 | CON | Concentra Group Holdings Parent, Inc. | 2.94B | 0.09% | 302,893 | 2.16B |
| 209 | RLAY | Relay Therapeutics, Inc. | 2.93B | -2.15% | 2,641,886 | 15.36M |
| 210 | NKTR | Nektar Therapeutics | 2.88B | 18.25% | 4,749,923 | 55.23M |
| 211 | KOD | Kodiak Sciences Inc. | 2.87B | 3.43% | 679,202 | - |
| 212 | RCUS | Arcus Biosciences, Inc. | 2.85B | -6.23% | 2,045,705 | 247.00M |
| 213 | ZLAB | Zai Lab Limited | 2.84B | 4.38% | 1,033,918 | 460.16M |
| 214 | HAE | Haemonetics Corporation | 2.84B | -0.73% | 585,173 | 1.32B |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.81B | -1.89% | 418,517 | 451.36M |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.78B | 0.95% | 283,846 | 1.10B |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.78B | -3.53% | 492,378 | - |
| 218 | MANE | Veradermics, Incorporated | 2.76B | -3.04% | 257,831 | - |
| 219 | IMNM | Immunome, Inc. | 2.74B | -1.54% | 985,411 | 6.94M |
| 220 | IRON | Disc Medicine, Inc. | 2.73B | -0.50% | 345,021 | - |
| 221 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.21% | 3,197,014 | 190.41M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.70B | -0.49% | 943,326 | 1.55M |
| 223 | LFST | LifeStance Health Group, Inc. | 2.70B | 0.44% | 1,551,124 | 1.42B |
| 224 | HTFL | HeartFlow, Inc. | 2.69B | 0.13% | 979,767 | 176.03M |
| 225 | VCYT | Veracyte, Inc. | 2.66B | -1.04% | 386,767 | 517.15M |
| 226 | LMAT | LeMaitre Vascular, Inc. | 2.63B | 0.56% | 154,348 | 249.60M |
| 227 | NHC | National HealthCare Corporation | 2.60B | -0.84% | 83,113 | 1.52B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | 3.11% | 3,458,017 | 3.31B |
| 229 | HCM | HUTCHMED (China) Limited | 2.56B | -0.51% | 72,790 | 548.51M |
| 230 | XRAY | DENTSPLY SIRONA Inc. | 2.55B | 2.24% | 4,961,424 | 3.68B |
| 231 | ADMA | ADMA Biologics, Inc. | 2.53B | -1.18% | 4,935,994 | 510.17M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -1.67% | 558,593 | - |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 1.01% | 1,447,588 | 673.00M |
| 234 | AAPG | Ascentage Pharma Group International | 2.42B | -3.80% | 1,928 | 82.08M |
| 235 | OGN | Organon & Co. | 2.41B | -5.12% | 7,249,764 | 6.22B |
| 236 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -0.53% | 274,290 | 1.45B |
| 237 | DFTX | Definium Therapeutics, Inc. | 2.31B | 2.20% | 5,987,891 | - |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.30B | -3.26% | 3,204,430 | 874.84M |
| 239 | PAHC | Phibro Animal Health Corporation | 2.29B | -0.98% | 139,405 | 1.46B |
| 240 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | -0.60% | 2,806,819 | 2.20B |
| 241 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | 0.76% | 1,432,394 | 276.98M |
| 242 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 1,604,992 | 158.18M |
| 243 | BHC | Bausch Health Companies Inc. | 2.21B | 0.17% | 1,268,923 | 10.27B |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.16B | 1.12% | 3,871,105 | - |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.16B | -2.17% | 746,023 | 184.42M |
| 246 | MESO | Mesoblast Limited | 2.13B | 0.91% | 216,243 | 65.38M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.56% | 842,919 | 283.06M |
| 248 | GRAL | GRAIL, Inc. | 2.10B | -0.99% | 350,351 | 147.17M |
| 249 | SNDX | Syndax Pharmaceuticals, Inc. | 2.10B | -1.86% | 859,613 | 172.35M |
| 250 | NEOG | Neogen Corporation | 2.10B | 1.26% | 1,487,070 | 870.56M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -3.05% | 3,386,134 | 51.95M |
| 252 | ZYME | Zymeworks Inc. | 2.05B | 0.18% | 311,827 | 105.97M |
| 253 | WGS | GeneDx Holdings Corp. | 2.04B | 5.69% | 581,222 | 427.54M |
| 254 | SEM | Select Medical Holdings Corporation | 2.04B | 0.12% | 1,539,228 | 5.45B |
| 255 | CAPR | Capricor Therapeutics, Inc. | 1.98B | -1.41% | 1,038,074 | 11.13M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 1.97B | -0.22% | 462,360 | 211.08M |
| 257 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -2.38% | 9,829,208 | 74.68M |
| 258 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | -4.30% | 770,402 | -665.00K |
| 259 | AXGN | Axogen, Inc. | 1.93B | -3.30% | 1,174,913 | 225.21M |
| 260 | GLPG | Galapagos NV | 1.93B | - | 67,771 | 1.31B |
| 261 | SION | Sionna Therapeutics, Inc. | 1.92B | -2.07% | 447,998 | - |
| 262 | PHVS | Pharvaris N.V. | 1.89B | 1.36% | 178,993 | - |
| 263 | AORT | Artivion, Inc. | 1.88B | 2.86% | 376,654 | 441.33M |
| 264 | MD | Pediatrix Medical Group, Inc. | 1.88B | 0.52% | 536,300 | 1.91B |
| 265 | ANIP | ANI Pharmaceuticals, Inc. | 1.86B | 1.00% | 347,624 | 883.37M |
| 266 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.47% | 3,058,382 | 9.77M |
| 267 | TYRA | Tyra Biosciences, Inc. | 1.85B | -3.35% | 1,290,785 | - |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -0.52% | 170,233 | - |
| 269 | SGRY | Surgery Partners, Inc. | 1.83B | 2.21% | 869,917 | 3.31B |
| 270 | VCEL | Vericel Corporation | 1.82B | 0.36% | 439,892 | 276.26M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 1.74% | 2,578,935 | 67.67M |
| 272 | ATAI | AtaiBeckley Inc. | 1.79B | 21.59% | 47,137,721 | 4.09M |
| 273 | NUVB | Nuvation Bio Inc. | 1.78B | 0.79% | 3,795,048 | 62.90M |
| 274 | RAPP | Rapport Therapeutics, Inc. | 1.78B | -6.47% | 242,162 | - |
| 275 | VIR | Vir Biotechnology, Inc. | 1.77B | 3.16% | 2,595,660 | 68.56M |
| 276 | INVA | Innoviva, Inc. | 1.77B | -1.32% | 590,035 | 411.33M |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.76B | -2.68% | 577,650 | 71.78M |
| 278 | ATEC | Alphatec Holdings, Inc. | 1.75B | 4.05% | 2,451,961 | 764.16M |
| 279 | AHCO | AdaptHealth Corp. | 1.72B | 0.08% | 1,037,370 | 3.24B |
| 280 | OMCL | Omnicell, Inc. | 1.72B | -1.25% | 697,117 | 1.18B |
| 281 | HRMY | Harmony Biosciences Holdings, Inc. | 1.71B | -1.53% | 724,847 | 868.45M |
| 282 | ADUS | Addus HomeCare Corporation | 1.70B | -0.85% | 135,702 | 1.42B |
| 283 | OCS | Oculis Holding AG | 1.69B | 4.19% | 619,579 | 1.51M |
| 284 | AHG | Akso Health Group | 1.69B | -1.50% | 192,435 | 14.84M |
| 285 | PRGO | Perrigo Company plc | 1.66B | 2.03% | 1,876,900 | 4.25B |
| 286 | INSP | Inspire Medical Systems, Inc. | 1.64B | -1.08% | 634,627 | 911.98M |
| 287 | BHVN | Biohaven Ltd. | 1.63B | -1.46% | 1,623,606 | - |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.62B | -0.14% | 529,923 | 336.39M |
| 289 | PLSE | Pulse Biosciences, Inc. | 1.61B | 1.41% | 270,123 | 350.00K |
| 290 | MBX | MBX Biosciences, Inc. | 1.60B | 0.03% | 503,304 | - |
| 291 | IMCR | Immunocore Holdings plc | 1.59B | 0.03% | 648,725 | 400.02M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.59B | -0.64% | 205,410 | - |
| 293 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -22.97% | 5,823,329 | 54.03M |
| 294 | NBTX | Nanobiotix S.A. | 1.59B | -5.56% | 82,706 | 38.27M |
| 295 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | 0.15% | 1,439,588 | 123.67M |
| 296 | IOVA | Iovance Biotherapeutics, Inc. | 1.56B | -2.07% | 9,751,118 | 263.50M |
| 297 | ASTH | Astrana Health, Inc. | 1.56B | -0.16% | 579,018 | 3.18B |
| 298 | UFPT | UFP Technologies, Inc. | 1.55B | -0.64% | 149,959 | 602.80M |
| 299 | ARDX | Ardelyx, Inc. | 1.55B | -2.33% | 3,076,288 | 407.32M |
| 300 | GENB | Generate Biomedicines, Inc. | 1.54B | -2.65% | 447,245 | 31.89M |
| 301 | BCAX | Bicara Therapeutics Inc. | 1.54B | -2.25% | 353,574 | - |
| 302 | ENOV | Enovis Corporation | 1.51B | -0.19% | 525,521 | 2.25B |
| 303 | IMTX | Immatics N.V. | 1.51B | 0.72% | 288,997 | 56.67M |
| 304 | HROW | Harrow, Inc. | 1.51B | -2.41% | 455,626 | 272.30M |
| 305 | VRDN | Viridian Therapeutics, Inc. | 1.50B | -0.81% | 1,694,765 | 70.85M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.49B | 1.48% | 1,654,268 | 2.43B |
| 307 | ALMR | Alamar Biosciences, Inc. | 1.47B | - | 1,069,454 | 74.21M |
| 308 | NVCR | NovoCure Limited | 1.47B | -1.25% | 811,014 | 655.35M |
| 309 | ANAB | AnaptysBio, Inc. | 1.46B | -24.53% | 1,118,086 | 234.60M |
| 310 | PGNY | Progyny, Inc. | 1.46B | 2.87% | 1,075,802 | 1.29B |
| 311 | ATRC | AtriCure, Inc. | 1.46B | -3.13% | 1,316,213 | 534.53M |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.46B | 3.06% | 1,718,591 | 1.01B |
| 313 | PGEN | Precigen, Inc. | 1.45B | 3.27% | 3,670,957 | 9.68M |
| 314 | ARDT | Ardent Health, Inc. | 1.45B | 2.52% | 359,546 | 6.32B |
| 315 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | 2.35% | 1,037,589 | 308.05M |
| 316 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | -1.43% | 1,155,446 | - |
| 317 | WVE | Wave Life Sciences Ltd. | 1.43B | 1.20% | 3,796,391 | 42.73M |
| 318 | SVRA | Savara Inc. | 1.42B | -2.94% | 944,643 | - |
| 319 | NVAX | Novavax, Inc. | 1.41B | -1.92% | 2,761,315 | 1.12B |
| 320 | BFLY | Butterfly Network, Inc. | 1.40B | 0.73% | 4,957,293 | 97.61M |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.39B | 5.90% | 622,235 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.36B | 2.19% | 412,392 | 83.72M |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.36B | 0.78% | 450,555 | 1.84B |
| 324 | MAZE | Maze Therapeutics, Inc. | 1.33B | -4.45% | 521,715 | 2.50M |
| 325 | GHRS | GH Research PLC | 1.33B | 17.23% | 1,454,024 | - |
| 326 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | -7.17% | 1,246,864 | - |
| 327 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.45% | 557,858 | - |
| 328 | STAA | STAAR Surgical Company | 1.26B | 1.79% | 559,991 | 239.44M |
| 329 | EYPT | EyePoint, Inc. | 1.26B | 0.94% | 803,381 | 31.37M |
| 330 | MPLT | MapLight Therapeutics, Inc. | 1.25B | -5.69% | 274,047 | - |
| 331 | DBVT | DBV Technologies S.A. | 1.25B | -1.59% | 293,656 | 5.64M |
| 332 | ZBIO | Zenas BioPharma, Inc. | 1.24B | -4.22% | 299,604 | 10.00M |
| 333 | PHAR | Pharming Group N.V. | 1.24B | 1.33% | 10,936 | 376.13M |
| 334 | CMPS | COMPASS Pathways plc | 1.22B | 42.04% | 39,750,965 | - |
| 335 | AZTA | Azenta, Inc. | 1.22B | 5.43% | 810,504 | 595.03M |
| 336 | URGN | UroGen Pharma Ltd. | 1.21B | 10.56% | 1,276,071 | 109.79M |
| 337 | SEPN | Septerna, Inc. | 1.21B | 2.79% | 654,628 | 45.95M |
| 338 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -6.62% | 242,350 | 1.30M |
| 339 | CNMD | CONMED Corporation | 1.20B | 1.54% | 409,486 | 1.37B |
| 340 | IRMD | IRADIMED CORPORATION | 1.19B | -0.83% | 89,556 | 83.81M |
| 341 | ABCL | AbCellera Biologics Inc. | 1.19B | -2.49% | 5,224,816 | 75.13M |
| 342 | NNNN | Anbio Biotechnology | 1.18B | -0.63% | 21,549 | 8.65M |
| 343 | CLOV | Clover Health Investments, Corp. | 1.17B | 1.83% | 3,177,477 | 1.92B |
| 344 | IVA | Inventiva S.A. | 1.17B | -1.41% | 219,601 | 7.94M |
| 345 | JBIO | Jade Biosciences, Inc. | 1.16B | 2.84% | 532,251 | - |
| 346 | AKTS | Aktis Oncology, Inc. | 1.15B | 2.86% | 196,144 | 6.50M |
| 347 | AVNS | Avanos Medical, Inc. | 1.15B | 0.08% | 878,900 | 701.20M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -1.11% | 211,360 | 773.34M |
| 349 | EVO | Evotec SE | 1.14B | -3.37% | 87,130 | 925.65M |
| 350 | QURE | uniQure N.V. | 1.14B | 2.62% | 2,221,804 | 16.10M |
| 351 | ALVO | Alvotech | 1.13B | 0.28% | 196,897 | 588.90M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -0.29% | 344,082 | 780.57M |
| 353 | TDOC | Teladoc Health, Inc. | 1.10B | 7.21% | 5,472,436 | 2.53B |
| 354 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 1.30% | 1,195,208 | - |
| 355 | CDNA | CareDx, Inc. | 1.09B | -0.61% | 603,971 | 379.81M |
| 356 | INNV | InnovAge Holding Corp. | 1.08B | -3.52% | 152,066 | 915.37M |
| 357 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.88% | 1,491,487 | 291.85M |
| 358 | BLFS | BioLife Solutions, Inc. | 1.07B | 3.21% | 658,256 | 96.21M |
| 359 | NEO | NeoGenomics, Inc. | 1.07B | -1.44% | 1,884,223 | 727.33M |
| 360 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | 2.12% | 762,644 | 175.11M |
| 361 | KALV | KalVista Pharmaceuticals, Inc. | 1.07B | 1.90% | 703,055 | 73.62M |
| 362 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 1.45% | 3,210,965 | 76.20M |
| 363 | CRON | Cronos Group Inc. | 1.05B | 2.60% | 1,217,316 | 146.59M |
| 364 | SANA | Sana Biotechnology, Inc. | 1.05B | 8.52% | 5,264,696 | - |
| 365 | PNTG | The Pennant Group, Inc. | 1.04B | -3.58% | 117,937 | 947.71M |
| 366 | ANNX | Annexon, Inc. | 1.03B | -1.68% | 1,429,295 | - |
| 367 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.02B | 0.17% | 542,349 | 719.89M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.73% | 798,862 | 726.41M |
| 369 | EVMN | Evommune, Inc. | 1.01B | 1.89% | 347,819 | 13.00M |
| 370 | GERN | Geron Corporation | 999.80M | -7.14% | 21,052,061 | 183.88M |
| 371 | FTRE | Fortrea Holdings Inc. | 976.14M | 0.58% | 590,146 | 2.72B |
| 372 | CMPX | Compass Therapeutics, Inc. | 975.18M | -9.75% | 2,761,918 | 850.00K |
| 373 | MGTX | MeiraGTx Holdings plc | 974.63M | 4.05% | 1,453,831 | 81.39M |
| 374 | OMER | Omeros Corporation | 969.79M | 0.22% | 1,103,034 | - |
| 375 | SSII | SS Innovations International, Inc. | 969.71M | -0.82% | 45,512 | 42.48M |
| 376 | JANX | Janux Therapeutics, Inc. | 965.40M | 0.32% | 2,506,758 | 10.00M |
| 377 | ANRO | Alto Neuroscience, Inc. | 957.99M | -1.41% | 334,880 | - |
| 378 | CERT | Certara, Inc. | 949.08M | -0.48% | 2,092,825 | 418.84M |
| 379 | SDGR | Schrödinger, Inc. | 944.96M | 3.73% | 1,291,919 | 255.87M |
| 380 | XNCR | Xencor, Inc. | 938.73M | -1.99% | 643,723 | 125.58M |
| 381 | MRVI | Maravai LifeSciences Holdings, Inc. | 928.01M | 6.49% | 2,494,519 | 185.74M |
| 382 | LMRI | Lumexa Imaging Holdings, Inc. | 927.46M | -0.10% | 1,110,229 | 1.02B |
| 383 | OPK | OPKO Health, Inc. | 926.06M | -1.61% | 1,332,424 | 606.88M |
| 384 | INMD | InMode Ltd. | 923.14M | -0.55% | 833,385 | 370.50M |
| 385 | LBRX | LB Pharmaceuticals Inc | 908.13M | 3.77% | 208,549 | - |
| 386 | ABUS | Arbutus Biopharma Corporation | 905.92M | -2.54% | 874,100 | 14.08M |
| 387 | MNKD | MannKind Corporation | 901.68M | 2.82% | 3,877,651 | 348.97M |
| 388 | SLS | SELLAS Life Sciences Group, Inc. | 896.12M | -4.41% | 6,420,421 | - |
| 389 | DRUG | Bright Minds Biosciences Inc. | 882.87M | 0.99% | 77,156 | - |
| 390 | CGEM | Cullinan Therapeutics, Inc. | 878.84M | -3.59% | 645,373 | - |
| 391 | QDEL | QuidelOrtho Corporation | 877.57M | 1.42% | 3,707,740 | 2.73B |
| 392 | IART | Integra LifeSciences Holdings Corporation | 869.78M | 0.18% | 706,963 | 1.64B |
| 393 | KURA | Kura Oncology, Inc. | 868.10M | 1.03% | 1,605,723 | 67.48M |
| 394 | TALK | Talkspace, Inc. | 865.45M | - | 1,269,603 | 228.87M |
| 395 | TBPH | Theravance Biopharma, Inc. | 860.96M | -2.96% | 471,522 | 107.46M |
| 396 | BVS | Bioventus Inc. | 854.83M | -2.28% | 401,555 | 568.09M |
| 397 | VOR | Vor Biopharma Inc. | 851.26M | -5.30% | 1,086,775 | - |
| 398 | FBRX | Forte Biosciences, Inc. | 842.79M | 1.50% | 178,435 | - |
| 399 | SLDB | Solid Biosciences Inc. | 835.37M | -1.62% | 877,944 | - |
| 400 | BIOA | BioAge Labs, Inc. | 834.34M | 1.68% | 637,388 | 9.00M |
| 401 | ALLO | Allogene Therapeutics, Inc. | 832.43M | 1.26% | 12,063,720 | 22.00K |
| 402 | TLRY | Tilray Brands, Inc. | 831.02M | 4.23% | 5,215,532 | 858.28M |
| 403 | OMDA | Omada Health, Inc. | 827.31M | -0.71% | 483,437 | 260.21M |
| 404 | SGP | SpyGlass Pharma, Inc. | 819.62M | -1.68% | 23,088 | - |
| 405 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | - | 965,330 | 84.28M |
| 406 | GDRX | GoodRx Holdings, Inc. | 811.90M | 4.41% | 1,426,745 | 796.85M |
| 407 | DSGN | Design Therapeutics, Inc. | 811.61M | 0.30% | 152,780 | - |
| 408 | CBLL | CeriBell, Inc. | 795.36M | -0.28% | 175,993 | 89.06M |
| 409 | AMN | AMN Healthcare Services, Inc. | 790.91M | 1.34% | 524,435 | 2.73B |
| 410 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.57M | -1.60% | 1,608,634 | 49.80M |
| 411 | RLMD | Relmada Therapeutics, Inc. | 773.03M | -1.47% | 2,201,232 | - |
| 412 | CSTL | Castle Biosciences, Inc. | 762.25M | 0.44% | 212,627 | 344.23M |
| 413 | NUTX | Nutex Health Inc. | 761.50M | 3.50% | 141,635 | 875.26M |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 741.10M | -0.96% | 872,945 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 725.03M | -1.98% | 50,627 | 116.59M |
| 416 | IRWD | Ironwood Pharmaceuticals, Inc. | 720.72M | -0.23% | 1,090,971 | 296.15M |
| 417 | CBIO | Crescent Biopharma, Inc. | 720.41M | 1.93% | 162,023 | 10.84M |
| 418 | DRTS | Alpha Tau Medical Ltd. | 713.76M | 1.00% | 247,999 | - |
| 419 | TENX | Tenax Therapeutics, Inc. | 709.24M | -2.42% | 521,586 | - |
| 420 | EHAB | Enhabit, Inc. | 695.92M | - | 602,983 | 1.06B |
| 421 | ARVN | Arvinas, Inc. | 691.42M | -1.73% | 540,348 | 262.60M |
| 422 | ETON | Eton Pharmaceuticals, Inc. | 689.75M | 0.96% | 305,531 | 79.95M |
| 423 | PRME | Prime Medicine, Inc. | 688.84M | 2.10% | 1,064,907 | 4.63M |
| 424 | KYTX | Kyverna Therapeutics, Inc. | 680.97M | 13.29% | 2,650,821 | - |
| 425 | ANL | Adlai Nortye Ltd. | 664.00M | 3.69% | 847,049 | 5.00M |
| 426 | PSNL | Personalis, Inc. | 663.66M | -5.79% | 2,803,089 | 69.65M |
| 427 | BWAY | BrainsWay Ltd. | 648.57M | -0.82% | 121,262 | 52.23M |
| 428 | PROK | ProKidney Corp. | 634.02M | -3.67% | 657,956 | 893.00K |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 632.91M | 1.03% | 633,028 | 106.47M |
| 430 | SIBN | SI-BONE, Inc. | 632.45M | 1.63% | 433,865 | 200.93M |
| 431 | HSTM | HealthStream, Inc. | 626.46M | -1.79% | 140,315 | 304.06M |
| 432 | EIKN | Eikon Therapeutics, Inc. | 625.30M | -2.94% | 163,076 | - |
| 433 | OCGN | Ocugen, Inc. | 625.11M | -7.04% | 11,316,996 | 4.41M |
| 434 | ABSI | Absci Corporation | 604.43M | 10.34% | 5,774,586 | 2.80M |
| 435 | RIGL | Rigel Pharmaceuticals, Inc. | 600.19M | 0.19% | 235,713 | 294.28M |
| 436 | CRMD | CorMedix Inc. | 599.20M | 2.57% | 1,043,090 | 311.71M |
| 437 | STTK | Shattuck Labs, Inc. | 595.58M | 4.65% | 1,013,030 | 1.00M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 590.73M | - | 1,076,021 | 7.83M |
| 439 | CTKB | Cytek Biosciences, Inc. | 587.47M | -0.87% | 409,600 | 201.49M |
| 440 | PRTA | Prothena Corporation plc | 580.86M | -1.01% | 333,299 | 9.68M |
| 441 | LYEL | Lyell Immunopharma, Inc. | 580.64M | 3.67% | 123,879 | 36.00K |
| 442 | TCMD | Tactile Systems Technology, Inc. | 580.59M | -0.82% | 138,939 | 329.52M |
| 443 | AVR | Anteris Technologies Global Corp. | 579.05M | -2.47% | 483,709 | 1.91M |
| 444 | BBNX | Beta Bionics, Inc. | 575.29M | -0.54% | 1,358,925 | 100.25M |
| 445 | PHR | Phreesia, Inc. | 573.00M | 2.84% | 1,438,585 | 480.59M |
| 446 | STRO | Sutro Biopharma, Inc. | 572.90M | 9.60% | 201,849 | 102.48M |
| 447 | VSTM | Verastem, Inc. | 572.74M | -0.91% | 1,954,399 | 30.91M |
| 448 | ENGN | enGene Therapeutics Inc. | 571.42M | 5.70% | 395,742 | - |
| 449 | EMBC | Embecta Corp. | 568.51M | -1.84% | 713,181 | 1.08B |
| 450 | NPCE | NeuroPace, Inc. | 556.51M | 2.10% | 127,439 | 99.99M |
| 451 | UPB | Upstream Bio, Inc. | 543.66M | - | 387,892 | 2.85M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 540.02M | -2.54% | 219,830 | - |
| 453 | ADCT | ADC Therapeutics SA | 539.94M | -0.70% | 844,332 | 81.36M |
| 454 | VALN | Valneva SE | 535.43M | 1.34% | 260,650 | 205.07M |
| 455 | IMMX | Immix Biopharma, Inc. | 534.89M | -2.51% | 568,433 | - |
| 456 | CADL | Candel Therapeutics, Inc. | 528.84M | 13.34% | 5,301,238 | - |
| 457 | FULC | Fulcrum Therapeutics, Inc. | 528.81M | -4.22% | 727,026 | 80.00M |
| 458 | AGMB | AgomAb Therapeutics NV | 525.87M | -4.77% | 351,180 | - |
| 459 | PACB | Pacific Biosciences of California, Inc. | 525.48M | 2.96% | 4,032,153 | 160.01M |
| 460 | ESPR | Esperion Therapeutics, Inc. | 518.76M | -0.98% | 5,489,177 | 403.14M |
| 461 | CATX | Perspective Therapeutics, Inc. | 518.40M | 8.33% | 2,037,258 | 884.00K |
| 462 | AQST | Aquestive Therapeutics, Inc. | 517.47M | -1.85% | 1,711,198 | 44.55M |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 514.09M | -4.00% | 473,091 | 85.21M |
| 464 | ZURA | Zura Bio Limited | 509.51M | -7.57% | 1,032,860 | - |
| 465 | OFIX | Orthofix Medical Inc. | 507.83M | -0.47% | 177,231 | 822.31M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 502.92M | -0.44% | 327,194 | - |
| 468 | VREX | Varex Imaging Corporation | 501.78M | -0.33% | 371,249 | 854.40M |
| 469 | LRMR | Larimar Therapeutics, Inc. | 499.68M | 0.21% | 862,710 | - |
| 470 | RGNX | REGENXBIO Inc. | 488.82M | -0.21% | 656,228 | 170.44M |
| 471 | TRDA | Entrada Therapeutics, Inc. | 488.16M | -3.07% | 134,091 | 25.42M |
| 472 | MYGN | Myriad Genetics, Inc. | 485.44M | 1.18% | 733,259 | 824.50M |
| 473 | LXEO | Lexeo Therapeutics, Inc. | 483.79M | -5.50% | 787,914 | - |
| 474 | KMDA | Kamada Ltd. | 482.84M | -2.00% | 32,511 | 180.46M |
| 475 | MDXG | MiMedx Group, Inc. | 482.84M | -4.83% | 2,523,104 | 418.63M |
| 476 | BNTC | Benitec Biopharma Inc. | 479.23M | -0.64% | 85,238 | - |
| 477 | XOMA | XOMA Royalty Corporation | 476.63M | 0.73% | 110,055 | 52.15M |
| 478 | IVVD | Invivyd, Inc. | 475.11M | -3.45% | 1,602,250 | 53.43M |
| 479 | AGL | agilon health, inc. | 469.63M | -5.82% | 627,552 | 5.93B |
| 480 | VTVT | vTv Therapeutics Inc. | 468.46M | -0.97% | 27,897 | 17.00K |
| 481 | FLGT | Fulgent Genetics, Inc. | 466.71M | -0.49% | 273,844 | 322.67M |
| 482 | DNA | Ginkgo Bioworks Holdings, Inc. | 464.49M | -0.62% | 944,933 | 170.16M |
| 483 | ALT | Altimmune, Inc. | 463.17M | 1.71% | 2,161,683 | 41.00K |
| 484 | CGC | Canopy Growth Corporation | 460.30M | 5.26% | 14,889,754 | 203.04M |
| 485 | ARMP | Armata Pharmaceuticals, Inc. | 457.91M | 8.70% | 82,495 | 4.90M |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 454.93M | -0.52% | 216,269 | - |
| 487 | AURA | Aura Biosciences, Inc. | 452.26M | -3.29% | 327,389 | - |
| 488 | ANGO | AngioDynamics, Inc. | 449.75M | -0.64% | 406,918 | 313.73M |
| 489 | ASMB | Assembly Biosciences, Inc. | 446.22M | -3.80% | 96,693 | 72.30M |
| 490 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.04M | 1.41% | 156,270 | - |
| 491 | PRTC | PureTech Health plc | 436.98M | 0.33% | 978 | 6.39M |
| 492 | NGNE | Neurogene Inc. | 432.03M | -0.39% | 173,978 | 925.00K |
| 493 | EBS | Emergent BioSolutions Inc. | 431.23M | -5.22% | 546,631 | 742.90M |
| 494 | WEAV | Weave Communications, Inc. | 430.21M | 2.63% | 676,091 | 239.02M |
| 495 | CLYM | Climb Bio, Inc. | 428.48M | -2.07% | 598,156 | - |
| 496 | CYH | Community Health Systems, Inc. | 421.67M | -0.32% | 1,616,269 | 12.49B |
| 497 | RCKT | Rocket Pharmaceuticals, Inc. | 421.21M | -1.28% | 1,751,851 | - |
| 498 | KIDS | OrthoPediatrics Corp. | 420.89M | -0.60% | 162,885 | 236.35M |
| 499 | IPSC | Century Therapeutics, Inc. | 420.55M | -10.00% | 1,135,547 | 109.16M |
| 500 | AUTL | Autolus Therapeutics plc | 420.51M | -1.25% | 887,482 | 75.39M |